About CET

Cellular Engineering Technologies (CET), founded in 2000, is an emerging biotechnology company in tissue engineering focused on developing novel technologies to expedite the drug discovery and screening processes. In addition, CET conducts research on non-embryonic stem cells with the ultimate goal of treating human disease. CET’s business focuses on three major themes: stem cell research, bioassay development and drug discovery.

Alan Moy, MD     Chief Executive Officer and Founder

Alan Moy, M.D., a physician-scientist, was previously on faculty for 13 years at the University of Iowa Department of Internal Medicine and Biomedical Engineering.  Dr. Moy founded the company in 2000. Dr. Moy received a Bachelor's degree in Biochemistry from the University of California, Davis and an M.D. from Creighton
University.  He received postgraduate education in Internal Medicine from St. Louis University and completed a fellowship in Pulmonary Medicine and Critical Care Medicine at the University of Iowa. Dr. Moy's research expertise is in the area of vascular biology and tissue engineering.